LA JOLLA PHARMACEUTICAL CO Finite-Lived Intangible Assets, Gross
LA JOLLA PHARMACEUTICAL CO had Finite-Lived Intangible Assets, Gross of $15.52 million as of 2022-06-30, per its 10-Q filed 2022-08-15.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization › Intangible Asset, Finite-Lived, after Accumulated Amortization
us-gaap:FiniteLivedIntangibleAssetsGross · last filed 2022-08-15
- 2022-06-30: Finite-Lived Intangible Assets, Gross $15.52M.
- 2022-03-31: Finite-Lived Intangible Assets, Gross $15.52M.
- 2021-12-31: Finite-Lived Intangible Assets, Gross $15.52M.
- 2021-09-30: Finite-Lived Intangible Assets, Gross $15.52M.
| Period end | Finite-Lived Intangible Assets, Gross |
|---|---|
| 2022-06-30 | $15.52M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $15.52M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $15.52M 10-Q · filed 2022-08-15 |
| 2021-09-30 | $15.52M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $15.52M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $15.52M 10-Q · filed 2021-05-07 |
| 2020-12-31 | $15.52M 10-K · filed 2022-03-09 |
| 2020-09-30 | $15.52M 10-Q · filed 2020-11-09 |